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Abstracts: The 16th International Congress on Nutrition and Metabolism in Renal Disease 2012 A65low serum albumin, high phosphorous, high C-reactive protein level, highmean
arterial pressure, low ejection fraction and high left ventricular ﬁlling pressure
(E/E’) were also frequent in higher cTnT group in simple analysis. Using cut
point of cTnT levelZ0.1 ng/ml, which was known as a valuable predictor of all-
cause and CV mortality in many studies, multiple logistic regression analysis
was undertaken for adjusting interaction among independent variables. After
adjusting confounding factors, log25(OH)D was independently associated with
elevated cTnT level (OR, 0.148; 95% CI, 0.026 to 0.832). Male sex and presence
of DM were also signiﬁcant independent variables (OR, 5.025; 95% CI, 1.566 to
16.125 and OR, 4.278; 95% CI, 1.315 to 13.915, respectively). However, other
variables, including log1,25(OH)2D did not show signiﬁcance in this regression
model. In conclusion, low 25(OH)D level was associated with elevated cTnT
level even in Korean ESRD patients, suggesting 25(OH)D deﬁciency partly plays
a role in poor CV outcome in this population like Western population.
http://dx.doi.org/10.1016/j.krcp.2012.04.515192
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Background: Our objective was to examine the association between the
Geriatric Nutritional Risk Index (GNRI) and Total lymphocytes count (TLC)
with mortality in Korean Hemodialysis Patients.Methods:We examined the
GNRI and TLC of 120 maintenance hemodialysis patients and followed these
patients for 120 months. Predictors for all-cause death were examined using
life table analysis and the Cox proportional hazards model. Results: Life table
analysis revealed that subjects with a GNRI o 90 (n ¼ 19) had a lower
survival rate than did those with a GNRI Z 90 (n ¼ 101) (Wilcoxon test, P ¼
0.048), but subjects with a TLC o 1500/mm3 (n ¼ 76)had a similar survival
rate compared those with a TLC Z 1500/mm3 (n ¼ 44) (Wilcoxon test, P ¼
0.500). Multivariate Cox proportional hazards analyses demonstrated that
the GNRI was a signiﬁcant predictor of mortality [hazard ratio (HR) 9.315,
95% conﬁdence interval (CI) 1.161–74.753, P ¼ 0.036], after adjusting for
age, sex, presence of type 2 diabetes mellitus, Kt/V, nPCR and TLC. The
association of a GNRI Z 90 with a TLC Z 1500/mm3 seemed to exclude the
occurring of complications with moderate reliability.
Conclusion: These results demonstrate that the GNRI may be a signiﬁcant
predictor of mortality in Korean hemodialysis patients. However, the use of
TLC might improve the evaluation of nutritional risk and the identiﬁcation of
patients at risk of malnutrition.Figure 1. Total lymphocytes count and 120-
month survival of hemodialysis patients. In both groups, survival rate during
the follow-up period was similar. (life table analysis, P ¼ 0.500).
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NATURAL CORRECTION OF HYPERURICEMIA, NOT BY ALLOPURINOL,
COULD SLOW DOWN THE PROGRESSION OF RENAL DISEASE IN THE
PATIENT WITH CHRONIC KIDNEY DISEASE STAGE 3
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Purpose: Correction of hyperuricemia can slow down the progression of
renal disease in animal study. However, there is limited data regarding the
effect of lowering serum uric acid in patients with hyperuricemic chronic
kidney disease (CKD) stage 3 (estimated GFR [eGFR] 30-60 mL/min).
Methods: We retrospectively investigated 100 patients (age 56.179.9
years, M:F¼79:21) with hyperuricemia (serum uric acid 7.970.9 mg/dL)
and CKD stage 3 (eGFR 52.077.0 mL/min) 10 years ago. First, to evaluate
the effect of allopurinol on the progression of renal disease, 23 patients
who have taken allopurinol were compared with the randomly selected 23
patients according to the level of serum uric acid and eGFR as a control
group among the other 77 patients who have never received allopurinol.
Second, to clarify the effect of lowering serum uric acid by diet on renal
disease progression, these 77 patients were divided into 2 groups by
decreased amount of serum uric acid during 10 years and compared each
other (group 141.0 mg/dL vs. group 2 o1.0 mg/dL).
Results: First, although serum uric acid levels were signiﬁcantly decreased
(8.571.0 to 6.671.2 mg/dL, po0.001) in subjects treated with allopurinol,
the change of eGFR was not signiﬁcant (48.878.6 to 44.5718.5 mL/min,
p¼0.230). In control group, serum uric acid was also decreased (8.271.0 to
7.371.6 mg/dL, p¼0.025) but eGFR did not change signiﬁcantly (49.078.7
to 50.3720.2 mL/min, p¼0.726). Second, eGFR increased signiﬁcantly
(54.076.0 to 63.1718.0 mL/min, p¼0.002) in the group 1 whereas eGFR
decreased (51.976.4 to 46.1715.6 mL/min, p¼0.008) in the group 2 after
10 years. In the multivariate linear regression analysis in the entire cohort
(n¼100), age (p¼0.023), change of serum creatinine (p¼0.001), and change
of serum uric acid (po0.001) were found to be signiﬁcant factors that
inﬂuence the change of eGFR during study period.
Conclusions: We identiﬁed the protective effect of lowering serum uric acid
against progression of renal disease in patients with CKD stage 3. However,
allopurinol itself did not have such beneﬁcial effect.
http://dx.doi.org/10.1016/j.krcp.2012.04.517194
WHAT TO EAT. THE TERAPEUTIC AND DIETETIC COMPLIANCE OF
PATIENTS ON PERITONEAL DIALYSIS.
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Nutrition education is important for patients on peritoneal dialysis. Yet,
despite initial nutrition training and monthly reinforcements during
follow-up visits, phosphorus control remains unsatisfactory. For this reason
a meeting with an external renal dietician open to patients and their
relatives was organized. Biographical data and average phosphorus levels
for the 3 months prior to the meeting are shown in Table.1Patients 11 (6 F - 5 M)
Age (years) 63 (47-81)
Time on Dialysis (months) 72 (6-348)
Body Mass Index (kg/m2) 25.8 (22.3-32.4)
Phosphorous mg/dl (average of 3 months) 5.95 (3.9-8.2)After a lecture delivered by the centre’s nephrologist, a questionnaire on
phosphorus control was compiled by the participants. The renal dietician
then explained how to: control dietary phosphorous intake, properly use
chelating agents, reduce phosphorous in cooking and make smart food
choices. A trained chef then demonstrated how to cook some regional
recipes speciﬁcally reworked to reduce their phosphorous content without
sacriﬁcing taste. Participants then veriﬁed that the recipes were indeed
appetizing. At this point, the same questionnaire given at the start of the
meeting was re-given. From this, an improvement in the understanding of
phosphorus control was seen. For example, in response to the question
‘‘Who is responsible for controlling phosphorus?’’ the percentage of
patients correctly answering ‘‘the patient’’ rose from 55% before the
meeting to 91% after the meeting. To successfully manage kidney disease
